Late 124I PET/CT Uptake Measurement—Assessment of Appropriate Examination Protocol in Benign Thyroid Diseases

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose

This study aimed at investigating the performance of late 124I PET/CT for radioiodine uptake (RAIU) measurement at 336 hours after administration in patients with benign thyroid diseases requiring radioiodine therapy. Special attention was paid to the comparability of 124I uptake (124I-RAIU) to the clinical standard (131I-RAIU, probe measurement). Considering cost aspects, we sought to establish an economically reasonable examination protocol based on scan duration and administered activity.

Methods

List-mode PET data sets of 40-minute acquisition time were acquired 336 hours after administration of 1 MBq 124I in 18 patients. Different scan durations were simulated by different reconstruction intervals (RIs) ranging from 5 seconds to 40 minutes, and total thyroid activity was measured. Mean 124I-RAIU levels of each RI were compared with mean 131I-RAIU levels (3 MBq). A hypothetical scan duration or hypothetical activity, respectively, was sought by means of a proportion equation, considering that the length of an RI is equitable to a hypothetical activity.

Results

After 336 hours, the mean total thyroid activity was 254 ± 7.7 kBq for 131I and 26.9 ± 8.7 kBq for 124I. The mean 124I-RAIU and 131I-RAIU showed high levels of agreement for RI from 2 minutes to 40 minutes. Reconstruction interval shorter than 2 minutes did not result in sufficient agreement.

Conclusions

The present study confirmed the feasibility of late 124I PET/CT as alternative method for RAIU measurement in patients with benign thyroid diseases; 1 MBq 124I PET/CT scans as short as 2 minutes resulted in RAIU levels comparable to those of standard 131I-RAIU. The parameter “appropriate scan-duration activity product” is proposed to enable an economically reasonable examination protocol.

    loading  Loading Related Articles